Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Evaluation of Nasociliary Clearance in Covid-19 Patients

Muhammed Ayral, Serkan Dedeoglu, Serdar Ferit Toprak.




Abstract
Cited by 0 Articles

Introduction: The new coronavirus 2019 (COVID-19), which rapidly turned into a global pandemic, progresses with mild flu-like symptoms, suggesting that there may be damage to the nasociliary clearance. The study aimed to evaluate whether nasociliary clearance in individuals with Covid-19 is affected or not using the saccharin test.
Materials and Methods: Saccharin test was applied to 47 PCR positive active COVID-19, 42 recovered PCR negative COVID-19, and 42 healthy groups to evaluate their nasociliary functions and the result was calculated in minutes.
Results: 42 (32.1%) recovered patients, 42 (32.1%) healthy, and 47 (35.9%) COVID-19 patients were included in the study. There were 13 women (31%), 29 men (69%) in the healthy, 18 women (42.9%), 24 men (57%) in the recovered group, 14 women (29.8%), and 33 men (70%) in the active patients. The mean times of saccharin nasociliary clearance were 24 (18-27) min in the active covid-19 patient group, 13 (8-17) min in the recovered covid-19 group, and 11 (8-13) min in the healthy. There was a difference between the groups in terms of the Saccharine test (p

Key words: COVID-19, nasal provocation tests, Saccharin, Smell, Upper respiratory tract infections






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.